[HTML][HTML] Protective effect of epigallocatechin-3-gallate (EGCG) in diseases with uncontrolled immune activation: could such a scenario be helpful to counteract COVID …

M Menegazzi, R Campagnari, M Bertoldi… - International Journal of …, 2020 - mdpi.com
Some coronavirus disease 2019 (COVID-19) patients develop acute pneumonia which can
result in a cytokine storm syndrome in response to Severe Acute Respiratory Syndrome …

Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?

M Menegazzi, R Campagnari… - International …, 2020 - pubmed.ncbi.nlm.nih.gov
Some coronavirus disease 2019 (COVID-19) patients develop acute pneumonia which can
result in a cytokine storm syndrome in response to Severe Acute Respiratory Syndrome …

Protective effect of epigallocatechin-3-gallate (EGCG) in diseases with uncontrolled immune activation: could such a scenario be helpful to counteract COVID-19?

M Menegazzi, R Campagnari, M Bertoldi, R Crupi… - 2020 - cabidigitallibrary.org
Abstract Some coronavirus disease 2019 (COVID-19) patients develop acute pneumonia
which can result in a cytokine storm syndrome in response to Severe Acute Respiratory …

Protective effect of epigallocatechin-3-gallate (EGCG) in diseases with uncontrolled immune activation: Could such a scenario be helpful to counteract COVID-19?

M Menegazzi, R Campagnari, M Bertoldi… - INTERNATIONAL …, 2020 - iris.univr.it
Abstract Some coronavirus disease 2019 (COVID-19) patients develop acute pneumonia
which can result in a cytokine storm syndrome in response to Severe Acute Respiratory …

Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?

M Menegazzi, R Campagnari… - International …, 2020 - search.ebscohost.com
Abstract Some coronavirus disease 2019 (COVID-19) patients develop acute pneumonia
which can result in a cytokine storm syndrome in response to Severe Acute Respiratory …

[PDF][PDF] Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract …

M Menegazzi, R Campagnari, M Bertoldi, R Crupi… - Int. J. Mol …, 2020 - researchgate.net
Some coronavirus disease 2019 (COVID-19) patients develop acute pneumonia which can
result in a cytokine storm syndrome in response to Severe Acute Respiratory Syndrome …

[HTML][HTML] Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract …

M Menegazzi, R Campagnari, M Bertoldi… - … Journal of Molecular …, 2020 - ncbi.nlm.nih.gov
Abstract Some coronavirus disease 2019 (COVID-19) patients develop acute pneumonia
which can result in a cytokine storm syndrome in response to Severe Acute Respiratory …

Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?

M Menegazzi, R Campagnari, M Bertoldi… - … Journal of Molecular …, 2020 - europepmc.org
Abstract Some coronavirus disease 2019 (COVID-19) patients develop acute pneumonia
which can result in a cytokine storm syndrome in response to Severe Acute Respiratory …

Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?

M Menegazzi, R Campagnari, M Bertoldi, R Crupi… - 2020 - agris.fao.org
Some coronavirus disease 2019 (COVID-19) patients develop acute pneumonia which can
result in a cytokine storm syndrome in response to Severe Acute Respiratory Syndrome …

[PDF][PDF] Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract …

M Menegazzi, R Campagnari, M Bertoldi… - Int. J. Mol …, 2020 - pdfs.semanticscholar.org
Some coronavirus disease 2019 (COVID-19) patients develop acute pneumonia which can
result in a cytokine storm syndrome in response to Severe Acute Respiratory Syndrome …